Arsenal Capital Exits ATP Adhesive Systems in Strategic Sale to Henkel

Arsenal Capital Partners closed the sale of ATP Adhesive Systems to Henkel AG this week, marking the exit of a specialty adhesives platform the New York-based private equity firm spent years assembling through acquisition. Financial terms weren't disclosed, but the deal hands Henkel a business serving aerospace, defense, and industrial OEMs with high-performance bonding solutions — a segment where Arsenal built ATP into what it now calls a market leader.

The transaction underscores the ongoing consolidation in industrial materials, where scaled platforms command premiums and strategic buyers like Henkel hunt for bolt-on growth in advanced manufacturing segments. Arsenal's playbook here was textbook buy-and-build: acquire a platform, tack on complementary businesses, professionalize operations, then flip to a corporate buyer with deeper pockets and global distribution.

ATP — formally ATP Adhesive Systems, headquartered in West Chicago, Illinois — manufactures structural adhesives, sealants, and coatings used in demanding applications where failure isn't an option. Think aircraft fuselages, satellite components, military hardware. The company's products meet stringent aerospace and defense certifications, which creates both technical moats and customer stickiness. That regulatory complexity also makes these businesses harder to replicate and more valuable to incumbents looking to expand without starting from scratch.

For Henkel — a $24 billion German conglomerate with adhesives, beauty, and laundry care divisions — the acquisition extends its industrial footprint in North America and adds specialized formulations that complement its existing Loctite and Bonderite portfolios. Henkel has been actively pursuing M&A in adhesives and surface treatments, viewing the segment as a growth driver amid slower consumer goods markets.

Arsenal didn't disclose when it initially acquired ATP or how many add-ons it completed during ownership, but the firm's typical hold period runs three to seven years. The sale comes as Arsenal continues to actively deploy from its sixth flagship fund, which closed in 2021 at $3.6 billion — a significant step up from prior vintages and a signal of the firm's growing scale in the lower-mid and mid-market.

The firm's thesis around ATP centered on fragmentation. The specialty adhesives market remains highly dispersed, with dozens of smaller manufacturers serving niche applications. Arsenal's model in these situations: buy a credible platform with strong customer relationships and technical capabilities, then consolidate adjacent players to achieve scale efficiencies, cross-selling opportunities, and multiple arbitrage on exit.

What makes adhesives attractive to financial buyers isn't just the fragmentation — it's the recurring revenue characteristics. Once an OEM qualifies a supplier's adhesive for a production line, switching costs are brutal. Re-qualification means testing, regulatory approval, potential production downtime. So customer churn tends to be low, and contracts often run multi-year with price escalators baked in.

ATP's customer base skews heavily toward aerospace and defense contractors, sectors that have seen robust demand over the past half-decade as defense budgets expanded and commercial aviation recovered post-pandemic. That end-market tailwind likely supported EBITDA growth during Arsenal's hold, making the business more attractive to a strategic like Henkel that can lever existing infrastructure to scale ATP further.

Henkel's adhesive technologies division — which also includes brands like Technomelt and Aquence — generated roughly €10.5 billion in sales in 2023, making it the company's largest business unit. The division serves automotive, electronics, packaging, and general industry, but aerospace and defense represent a smaller, faster-growing slice where Henkel has been selectively investing.

ATP's technical certifications and customer relationships in aerospace give Henkel immediate credibility in a segment that typically takes years to penetrate organically. For a company Henkel's size, buying expertise and market position is often more efficient than building it — especially when the target already holds approvals from major OEMs and defense primes.

The deal also strengthens Henkel's North American manufacturing footprint. ATP operates production facilities in the U.S., and nearshoring trends have made domestic supply chains more valuable to aerospace and defense customers wary of geopolitical risk. Henkel can now serve those customers locally while leveraging ATP's formulations across its global network.

Henkel didn't comment publicly on integration plans or growth targets, but the company's recent M&A pattern suggests it will likely maintain ATP's brand and operations as a specialized unit within the adhesives division rather than folding it into a broader platform immediately. That approach preserves customer relationships and technical continuity — critical in regulated markets like aerospace.

Arsenal's successful exit of ATP contrasts with the broader PE market's sluggish exit environment over the past two years. Elevated interest rates, volatile public markets, and cautious corporate M&A activity have squeezed traditional exit routes — IPOs have been largely shut, and sponsor-to-sponsor deals often require pricing concessions.

Yet the mid-market — where Arsenal primarily operates — has shown more resilience. Strategic buyers remain active for high-quality assets in defensive, cash-generative sectors. Industrial businesses with technical moats, recurring revenue, and exposure to secular growth themes (like defense modernization or advanced manufacturing) continue to attract premium valuations from corporates with strong balance sheets and acquisition capacity.

The table below illustrates recent comparable exits in the industrial materials and adhesives space, providing context for where ATP likely fits in the market landscape:

What stands out: adhesives and specialty materials assets consistently find homes with either large strategics or well-capitalized financial buyers. The sector's combination of technical barriers, sticky customer relationships, and exposure to infrastructure and manufacturing trends makes it perennially attractive — even when broader M&A volumes sag.

Arsenal Capital, founded in 2000, focuses on specialty industrials and healthcare with a buy-and-build approach. The firm's sixth flagship fund — Arsenal Capital Fund VI — closed in May 2021 at $3.6 billion, marking a significant fundraising milestone and positioning the firm to pursue larger platforms and more aggressive consolidation strategies.

The broader industrial adhesives market — valued at roughly $20 billion in North America and $65 billion globally — remains fragmented despite decades of consolidation. Large players like Henkel, H.B. Fuller, 3M, and Sika dominate commodity adhesives and mass-market applications, but specialty niches like aerospace-grade structural adhesives, high-temperature sealants, and defense-certified coatings are still populated by dozens of smaller, privately held manufacturers.

That fragmentation creates opportunity for both PE roll-ups and strategic acquirers. Private equity firms like Arsenal, Littlejohn, and Platinum have been active in the space for years, assembling platforms and exiting to corporates. Meanwhile, the strategics themselves — Henkel, H.B. Fuller, Arkema — pursue tuck-ins to fill portfolio gaps and gain access to specialized formulations or customer relationships that would take years to develop in-house.

Several trends are accelerating consolidation. First, regulatory complexity in aerospace and defense is rising, making it harder for small players to maintain certifications and keep pace with evolving standards. Second, supply chain pressures post-pandemic have pushed OEMs to consolidate their supplier bases, favoring larger, more reliable partners. Third, automation and digitization in manufacturing require capital investment that smaller adhesives companies often can't justify.

For Arsenal, the ATP exit validates its thesis that fragmented industrial niches with technical moats and recurring revenue can be bought, built, and sold at attractive multiples — even in a challenging macro environment. The firm's ability to deliver returns on this deal likely strengthens its case to LPs as it raises future funds.

One question the deal leaves open: how much growth did Arsenal drive at ATP during its hold? The press release emphasizes market leadership and customer breadth but offers no financial metrics — no revenue figures, no EBITDA growth rates, no employee count. That opacity is typical for mid-market PE exits where neither buyer nor seller is public, but it makes it harder to assess how much value creation came from operational improvements versus market tailwinds.

Henkel's adhesives division has been acquisitive in recent years, completing roughly a dozen deals since 2020 across geographies and end markets. The ATP acquisition fits a pattern: targeted tuck-ins in high-margin, technically complex segments where Henkel can apply its scale and distribution to accelerate growth.

The company has telegraphed ambitions to grow its adhesives business faster than its consumer-facing divisions, which face sluggish demand in mature markets. Industrial adhesives offer better margin profiles and more predictable revenue — exactly what a conglomerate like Henkel wants as it navigates a slower European economy and softening consumer spending.

ATP's focus on aerospace and defense adhesives positions it in a segment experiencing both tailwinds and complexity. U.S. defense spending has trended upward, with the DoD budget exceeding $800 billion annually and significant allocations toward modernization programs that require advanced materials. Commercial aerospace, meanwhile, has rebounded from the pandemic trough, with Boeing and Airbus facing strong order backlogs despite production challenges.

But serving these customers isn't straightforward. Adhesive suppliers must navigate rigorous testing protocols, maintain traceability documentation, and comply with regulations like ITAR (International Traffic in Arms Regulations) for defense applications. These barriers make the market difficult to enter but also create pricing power for incumbents who've already jumped through the hoops.

ATP's product portfolio likely includes epoxy-based structural adhesives, polyurethane sealants, and specialty coatings designed to withstand extreme temperatures, vibration, and environmental exposure. These aren't commodity products — formulations are often customized for specific applications, and suppliers work closely with OEM engineering teams during design and qualification phases.

That intimacy with customers is both a strength and a challenge. On one hand, it creates deep relationships and high switching costs. On the other, it limits scalability — you can't easily replicate a custom adhesive developed for one aerospace program and sell it into a different vertical. Growth often requires winning new programs or acquiring adjacent capabilities, which is exactly the strategy Arsenal pursued.

One underappreciated aspect of the adhesives business in aerospace and defense: pricing dynamics. Because formulations are often qualified at the program level and switching costs are high, suppliers have more latitude to pass through raw material cost increases than they would in consumer or commodity industrial markets. Contracts frequently include price escalators tied to inflation or material indices.

That pricing power helped adhesives companies weather the commodity inflation spike of 2021-2022 without seeing margin compression — a trait that likely made ATP more attractive to Arsenal's investors and, ultimately, to Henkel.

Neither Arsenal nor Henkel disclosed the purchase price, and no regulatory filings are available since both are private on the deal (Henkel is public, but the acquisition is likely immaterial to its overall financials and wouldn't trigger detailed disclosure). That makes valuation guesswork, but we can triangulate.

Mid-market industrial adhesives businesses with strong customer concentration in aerospace and defense typically trade at 10-14x EBITDA to strategic buyers, sometimes higher if growth is robust and the regulatory moat is wide. If ATP was generating, say, $15-25 million in EBITDA — a reasonable estimate for a platform Arsenal would pursue — the deal likely valued the business somewhere in the $150-300 million range.

These are rough estimates — the actual figures could be higher or lower depending on ATP's margin profile, growth trajectory, and the competitiveness of the sale process. But the order of magnitude feels consistent with Arsenal's fund size and deal flow.

What we don't know: how much Arsenal originally paid, how much it invested in add-ons and operational improvements, and what its gross multiple of invested capital (MOIC) looks like on exit. If the firm bought ATP in 2018 or 2019 at, say, 8x EBITDA and sold at 12x after doubling EBITDA through organic growth and acquisitions, the return could be in the 3-4x range — solid, not spectacular, but exactly the kind of outcome that keeps LP capital flowing into industrial PE.

The ATP-Henkel transaction is a data point, not a trend — but it aligns with what practitioners are seeing in mid-market industrials right now. Quality assets in defensive, cash-generative niches are finding homes. Strategic buyers with strong balance sheets are willing to pay for technical capabilities, customer relationships, and market position. And PE firms that executed disciplined buy-and-build strategies during the low-rate era are successfully exiting, even if the broader market remains challenging.

What's harder: exiting commodity industrial businesses, cyclical plays, or platforms that didn't achieve the scale or margin improvements promised at entry. Those deals are getting repriced, delayed, or restructured. But specialty niches with recurring revenue and technical moats — like aerospace adhesives — remain liquid.

For Arsenal, the ATP exit likely clears capital for redeployment and generates carry for the team. For Henkel, it's a bolt-on that strengthens a division already performing well. And for the adhesives market, it's another data point in a long-running consolidation story that shows no signs of ending.

The deal also raises a question worth watching: as PE firms continue to consolidate fragmented industrial niches and flip them to strategics, how long before the next wave of consolidation targets becomes harder to find — or more expensive to acquire? At some point, the low-hanging fruit gets picked, and returns compress. We're not there yet in adhesives, but the dynamic is worth tracking as firms like Arsenal raise larger funds and chase similar theses.

Arsenal's sale of ATP to Henkel is the kind of transaction that doesn't make headlines but tells you something important about where value still gets created in private equity. It's not flashy. It's not venture-scale returns. It's the patient work of buying a decent business, making it better, and selling it to someone who can scale it further.

The absence of drama is the point. In a market where exits have been hard to come by, completing a strategic sale to a credible buyer at what likely represents a healthy return is worth noting. It suggests that the fundamentals — strong customer relationships, technical differentiation, exposure to resilient end markets — still matter, even when macro conditions are mixed.

What happens next at ATP under Henkel's ownership will be telling. Does the German giant invest in capacity expansion? Push ATP's formulations into new geographies? Fold it into a larger adhesives platform? Or does it run the business as a steady cash generator with minimal integration?

For now, the deal is done, the capital is returned, and another fragmented industrial niche gets a little more consolidated. Which, in mid-market PE, counts as a win.